||Recombinant Human USP2 (Accession # O75604), fused with , was produced in E. coli.
||2.0 mg/ml (50 µM) in 50 mM HEPES pH 8.0, 150 mM NaCl, 0.1 mM EDTA, and 1 mM DTT.
||Recombinant Human USP2 Catalytic Domain is a Ubiquitin-specific deconjugating enzyme. Reaction conditions will need to be optimized for each specific application. We recommend an initial Recombinant Human USP2 Catalytic Domain concentration of 1-5 nM.
||Recombinant Human USP2 has a calculated MW of 40 kDa.
||>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
||Reconstitute at 100 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.